Plasmacytoma
📧 Sign up to get email alerts when something new happens for Plasmacytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Engineered Dendritic Cell Vaccines for Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating an engineered dendritic cell vaccine for multiple myeloma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a frontline combination CAR-T cell therapy for multiple myeloma or plasmacytoma is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma [Phase 2]
Phase 2 clinical trial assessing lenalidomide and CC-486 with radiation therapy in patients with plasmacytoma; the study is currently active…
-
CLINICAL_TRIALS research · 2017-04-24Clinical Trial Update: S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma [Phase 2]
Phase 2 clinical trial S0340 evaluating MRI and FDG PET for diagnosing solitary plasmacytoma was terminated, per SWOG Cancer Research Networ…
-
CLINICAL_TRIALS research · 2016-10-07Clinical Trial Update: S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
This clinical trial update describes the S0120 study that collects blood and bone marrow samples from patients with monoclonal gammopathy of…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.